Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
International Journal of Clinical Oncology
|
June 2, 2026
Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression
Takashi Hiroshima, Toru Kimura, Tadashi Watabe, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Preclinical Evaluation of Biodistribution and Toxicity of [<sup>211</sup>At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with <sup>89</sup>Zr or <sup>211</sup>At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.
Anticancer Research
|
August 30, 2023
The Clinical Potential of FBPA-PET/CT Imaging for Colorectal Cancer and its Liver Metastases Expressing LAT1
Takayuki Minoji, Hidekazu Takahashi, Tadashi Watabe, et al.
Scientific Reports
|
February 11, 2026
Intravenous high mobility group box 1 fragment improves cardiac function, fibrosis, and coronary flow in porcine ischemic cardiomyopathy model
Yoshito Ito, Masashi Kawamura, Takuji Kawamura, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target
Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Journal of Medicinal Chemistry
|
October 28, 2021
Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High <i>In Vivo</i> Stability
Hiroyuki Suzuki, Yuta Kaizuka, Maho Tatsuta, et al.
Cancer Science
|
December 5, 2020
α-Emitting cancer therapy using <sup>211</sup> At-AAMT targeting LAT1
Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
Clinical Nuclear Medicine
|
September 8, 2023
Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison
Tadashi Watabe, Naoko Ose, Sadahiro Naka, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
International Journal of Clinical Oncology
|
June 2, 2026
Fibroblast activation protein inhibitor-PET/CT in lung cancer: a prospective single-center study with histopathological correlation of fibroblast activation protein expression
Takashi Hiroshima, Toru Kimura, Tadashi Watabe, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Preclinical Evaluation of Biodistribution and Toxicity of [<sup>211</sup>At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer
Tadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 12, 2023
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with <sup>89</sup>Zr or <sup>211</sup>At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
Tadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.
Anticancer Research
|
August 30, 2023
The Clinical Potential of FBPA-PET/CT Imaging for Colorectal Cancer and its Liver Metastases Expressing LAT1
Takayuki Minoji, Hidekazu Takahashi, Tadashi Watabe, et al.
Scientific Reports
|
February 11, 2026
Intravenous high mobility group box 1 fragment improves cardiac function, fibrosis, and coronary flow in porcine ischemic cardiomyopathy model
Yoshito Ito, Masashi Kawamura, Takuji Kawamura, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target
Kentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.
Journal of Medicinal Chemistry
|
October 28, 2021
Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High <i>In Vivo</i> Stability
Hiroyuki Suzuki, Yuta Kaizuka, Maho Tatsuta, et al.
Cancer Science
|
December 5, 2020
α-Emitting cancer therapy using <sup>211</sup> At-AAMT targeting LAT1
Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2025
Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0
Emil Novruzov, Gabriel T Sheikh, Eduards Mamlins, et al.
Clinical Nuclear Medicine
|
September 8, 2023
Evaluation of LAT1 Expression in Patients With Lung Cancer and Mediastinal Tumors: 18F-FBPA PET Study With Immunohistological Comparison
Tadashi Watabe, Naoko Ose, Sadahiro Naka, et al.
Page
of 19